NCT05557370Active, not recruitingPhase 4
Immunogenicity of HPV Vaccine in Transplant Recipients.
Prospective Analysis of Immunogenicity of the Nonavalent Human Papillomavirus Vaccination (GARDASIL 9) in Patients Post Solid Organ Transplant
Source: ClinicalTrials.gov · Last updated 1 May 2026
Brief summary (registry, in English)
To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 14 Sept 2022
- Start date
- 1 Jun 2023
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Medical College of Wisconsin
- Diseases
- Chronic kidney disease
- NCT number
- NCT05557370
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 30
- From 1 Jun 2023 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindication: Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL.
- Patient had completed vaccination series with a nonavalent HPV vaccine (e.g., GARDASIL 9) in the past
Other illness
- Patient with a diagnosis of HIV.
Other
- Patient that endorses being currently pregnant.
Who the study is looking for
- Patient between the age of 18 and 45 years
- Patient is at least 6 months post-solid-organ transplant and has not received GARDASIL 9.
- Patient who can participate in their health care and sign informed consent.
- Patient may have had bivalent or quadrivalent HPV vaccination previously.
- Living or deceased donor transplant patient is eligible.
Age in the registry: 18 years to 45 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Froedtert Lutheran Memorial Hospital Coordinator of this site? Confirm its status | Milwaukee | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.